91013-48-8

Upstream product

• 93-89-0 benzoic acid ethyl ester 
• 624-90-8 Methanesulfonyl azide 
• 65-85-0 benzoic acid 
• 124-63-0 methanesulfonyl chloride 
• 87-25-2 2-ethoxycarbonylaniline 

Downstream Products

• 1000986-47-9 C₁₇H₁₈ClNO₄S 
• 1000986-43-5 C₁₂H₁₇NO₄S 
• 1000986-46-8 C₁₇H₁₉NO₄S 
• 1000986-44-6 C₁₃H₁₉NO₄S 
• 1000986-45-7 C₁₄H₂₁NO₄S 
• 162787-61-3 2-(methylsulfonamido)benzoic acid 
• 866010-09-5 2-(methanesulfonyl methylamino)benzoic acid ethyl ester 
• 42091-29-2 4-ethoxy-1H-2,1-benzothiazine 2,2-dioxide 
• 1315379-74-8 4-ethoxy-1H-2,1-benzothiazine 2,2-dioxide 
• 1315379-70-4 ethyl 2-[benzoyl(methylsulfonyl)amino]benzoate 
• 1025713-67-0 1-(2-methanesulfonylamino-benzoyl)-piperidine-3-carbonyl chloride 
• 1025713-53-4 1-(2-methanesulfonylamino-benzoyl)-piperidine-3-carboxylic acid 
• 1025713-51-2 1-(2-methanesulfonylamino-benzoyl)-piperidine-3-carboxylic acid ethyl ester 
• 1025712-70-2 N-(2-(3-(1-cyclohexyl-3-methyl-4-oxo-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-yl)piperidine-1-carbonyl)phenyl)methanesulfonamide 

Relevant academic research and scientific papers

Diverse Redoxome Reactivity Profiles of Carbon Nucleophiles

Targeted covalent inhibitors have emerged as a powerful approach in the drug discovery pipeline. Key to this process is the identification of signaling pathways (or receptors) specific to (or overexpressed in) disease cells. In this context, fragment-base

AMIDE DERIVATIVE COMPOUND

An embodiment of the present invention relates to an amide derivative compound or benzo [c] [1,2] Cy-azine derivative compound, a prodrug thereof, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, and a solvate thereof. Ano

Iridium-catalyzed direct C-H amidation with weakly coordinating carbonyl directing groups under mild conditions

An iridium-catalyzed direct C-H amidation of weakly coordinating substrates, in particular of those bearing ester and ketone groups, under very mild conditions has been developed. The observed high reaction efficiency was achieved by the combined use of acetic acid and lithium carbonate as additives. Copyright

TRICYCLIC INHIBITORS OF KINASES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES

The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein R1, R2, R3, A, B, and n are defined in the description. The present invention relates also to compositions containing sa

PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a] PYRIDINE DERIVATIVES

This application relates to compounds of the general Formula I and salts thereof, wherein X, R1A, R1B, R2, R3, R4, and R5 are as defined herein. The application also relates to compositions and methods of treatment of hyperproliferative diseases or disorders.

NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE and INFLAMMATORY DISEASES

The present invention relates to compounds of formula (I) that are inhibitors of PDElA, a phosphodiesterase that is involved in the modulation of the degradation of cartilage, joint degeneration and diseases involving such degradation and/or inflammation.

N-alkyl-4-chloro-1H-benzo[c][1,2]thiazine-3-carbaldehyde-2,2-dioxides - New functional benzothiazine derivatives

(Chemical Equation Presented) A synthesis of N-alkyl-4-chloro-1H-benzo[c] [1,2]thiazine-3-carbaldehyde-2,2-dioxides is described. Reactivity of new β-chloroaldehydes is investigated, a number of novel benzo[c][1,2]thiazine derivatives are synthesized and characterized using 1H, 13C-NMR, MS and elemental analysis.